Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/1K9 stock hub

FRA/1K9 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/1K9is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

957.7M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/1K9FRA/1K9

—

Loading chart…

In the news

Latest news · FRA/1K9

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.5

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-2.4

P25 n/aP50 n/aP75 n/a

ROIC-8.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/1K9 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

USD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	763
Employees Change	115%
Employees Change Percent	17.69
Enterprise value	EUR 810.2M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	In Vitro and In Vivo Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 957.7M
Price	EUR 18.1
Price currency	EUR
Rev Per Employee	469,251.36x
Sic	2835
Symbol	fra/1K9
Website	https://caredx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.74%
EV Earnings	-114.03x
EV/EBITDA	98.7x
EV/FCF	14.41x
EV/Sales	2.31x
FCF yield	5.87%
Forward P/E	24.47x
P/B ratio	3.52x
P/S ratio	2.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.15%
EBITDA Margin	0.56%
FCF margin	15.71%
Gross margin	68.88%
Gross Profit	EUR 246.6M
Gross Profit Growth	21.4%
Gross Profit Growth Q	49.41%
Gross Profit Growth3 Y	10.93%
Gross Profit Growth5 Y	13.81%
Net Income	EUR -7.1M
Pretax Margin	-1.94%
Profit Margin	-1.98%
Profit Per Employee	EUR -9,312
ROA	-1.8
Roa5y	-7.27
ROCE	-3.92
ROE	-2.36
Roe5y	-14.03
ROIC	-8.58
Roic5y	-47.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	46.07%
Cagr3y	33.24%
Cagr5y	-22.2%
FCF Growth	221.84%
OCF Growth	172.44%
OCF Growth5 Y	91.18%
Revenue Growth	19.17x
Revenue Growth Q	38.99x
Revenue Growth3 Y	8.9x
Revenue Growth5 Y	13.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.92
Assets	EUR 356.5M
Cash	EUR 162.3M
Current Assets	EUR 228.4M
Current Liabilities	EUR 67.1M
Debt	EUR 21.2M
Debt EBITDA	EUR 2.54
Debt Equity	EUR 0.08
Debt FCF	EUR 0.38
Equity	EUR 271.9M
Liabilities	EUR 84.6M
Long Term Assets	EUR 128.1M
Long Term Liabilities	EUR 17.5M
Net Cash	EUR 150.5M
Net Cash By Market Cap	EUR 15.72
Net Cash Growth	-13.49%
Net Debt EBITDA	EUR -74.95
Net Debt Equity	EUR -0.55
Net Debt FCF	EUR -2.68
Tangible Book Value	EUR 209.1M
Tangible Book Value Per Share	EUR 4.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.4
Inventory Turnover	5.21
Net Working Capital	EUR 8.4M
Quick ratio	2.93
Working Capital	EUR 165M
Working Capital Turnover	EUR 1.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	9.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	46.03%
200-day SMA	14.3
3Y total return	136.6%
50-day SMA	15.85
50-day SMA vs 200-day SMA	50over200
5Y total return	-71.5%
All Time High	80.36
All Time High Change	-77.48%
All Time High Date	2021-01-21
All Time Low	4.58
All Time Low Change	295.2%
All Time Low Date	2023-10-26
ATR	0.59
Ch YTD	12.25
High	18.1
High52	18.8
High52 Date	2026-04-17
High52ch	-3.72%
Low	18.1
Low52	9.83
Low52 Date	2025-08-20
Low52ch	84.17%
Ma50ch	14.23%
Price vs 200-day SMA	26.56%
RSI	58.48
RSI Monthly	53.42
RSI Weekly	58.13
Sharpe ratio	0.73x
Sortino ratio	1.09
Total Return	9.13%
Tr YTD	12.25
Tr1m	19.87%
Tr3m	17.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -11.3M
Operating margin	-3.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,476,772%
Shares Insiders	4.23%
Shares Institutions	100.74%
Shares Qo Q	3.92%
Shares Yo Y	-9.13%
Short Ratio	9.23

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 25.2M
Average Volume	0x
Bv Per Share	5.3
CAPEX	EUR -7M
Ch1m	19.87
Ch1y	46.03
Ch3m	17.88
Ch3y	136.6
Ch5y	-71.5
Ch6m	39.93
Change	2.84%
Change From Open	0
Close	17.6
Days Gap	2.84
Depreciation Amortization	12,988,234
Earnings Date	2026-04-28
EBIT	EUR -11.3M
EBITDA	EUR 2M
EPS	EUR -0.14
F Score	4
FCF	EUR 56.2M
FCF EV Yield	6.94x
Financing CF	-82,967,653
Fiscal Year End	December
Founded	1,998
Goodwill	34,203,395.2
Income Tax	EUR 156,981
Investing CF	10,313,932
Is Primary Listing	0
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Ma150	15.34
Ma150ch	18.01%
Ma20	16.87
Ma20ch	7.29%
Net CF	-9,385,053
Next Earnings Date	2026-08-04
Open	18.1
P FCF Ratio	17.03
P OCF Ratio	15.14
Ppne	46,096,910.2
Price Date	2026-05-08
Price EBITDA	EUR 477
Ptbv Ratio	4.58
Relative Volume	105.26x
Revenue	358,038,786x
SBC By Revenue	8.66x
Share Based Comp	30,993,833
Tax By Revenue	0.04x
Tr6m	39.93%
Volume	0
Z Score	4.5

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/1K9 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/1K9 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/1K9?

Insider, institutional, and short-interest positioning.

Institutional ownership

+100.7%

Share of float held by funds and institutions

Insider ownership

+4.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/1K9 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.5

Neutral momentum band

Price vs 200-day MA

+26.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/1K9

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/1K9 stock rating?

fra/1K9 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/1K9 analysis?

The full report lives at /stocks/fra/1K9/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/1K9?

The latest report frames fra/1K9 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/1K9 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.